Cardiac Arrest Clinical Trials

Find Cardiac Arrest Clinical Trials Near You

Neuroprotection Following Cardiac Arrest: A Randomized Control Trial of Magnesium

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

The purpose of this pilot interventional study is to collect preliminary data on administering magnesium sulfate as a neuroprotective medication in patients who achieved Return of Spontaneous Circulation (ROSC) following Cardiac Arrest (CA). The primary aims are to assess the feasibility and safety of administering magnesium and measure serum markers of neuronal injury at prespecified time points in the post-cardiac arrest period. Because this is a pilot study with a limited sample size, the primary objective is to evaluate the precision and stability of the collected measures to inform the design and formal analysis in a larger trial.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Documented post-cardiac arrest patient with Return of Spontaneous Circulation (ROSC) achieved \<2 hours prior to recruitment

Locations
United States
New York
NYU Langone Health
RECRUITING
New York
Contact Information
Primary
Anelly Gonzales
resuscitationlab@nyulangone.org
646-501-6923
Backup
Natalia Leontovich
resuscitationlab@nyulangone.org
646-501-6923
Time Frame
Start Date: 2025-03-25
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 178
Treatments
Experimental: Magnesium Sulfate
Treatment of initial magnesium sulfate bolus followed by a continuous drip.
Placebo_comparator: Saline solution
Treatment of equivalent volume of normal saline.
Related Therapeutic Areas
Sponsors
Leads: NYU Langone Health
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials